Dinara Shashanka Gunasekera - Nanotechnology

Author Information

Dinara Shashanka Gunasekera is affiliated with the Sri Lanka Institute of Nanotechnology, Nanotechnology & SciencePark, Mahewatta, Pitipana, Homagama 10200, Sri Lanka. Her research spans various aspects of nanotechnology and related fields, contributing significantly to advancements in drug delivery, synthesis methods, and biological evaluation techniques.

Research Contributions

Dinara Shashanka Gunasekera has made substantial contributions to the field of nanotechnology. Her research work includes the efficient synthesis of pharmaceutical compounds such as beclomethasone dipropionate and Levothyroxine. She has also focused on the extraction and purification of linamarin from Cassava and developed rapid detection methods for its quantification. Her work on nanotechnological strategies to improve the water solubility of drugs and receptor-mediated delivery systems for pDNA nanoparticles showcases her innovative approach to addressing contemporary challenges in drug delivery and nanomedicine.

Aliases

Dinara Shashanka Gunasekera is also known by the following aliases: Dinara Gunasekera, Dinara S Gunasekera, and Dinara S. Gunasekera.

Publication and Citation Metrics

Publication Year	Title	DOI
2022	Practical and scalable synthesis of beclomethasone dipropionate	10.1016/j.steroids.2021.108948
2020	Updating Levothyroxine Synthesis for the Modern Age.	10.2174/1570179417666201231110306
2020	An efficient and high-yielding method for extraction and purification of linamarin from Cassava; in vitro biological evaluation	10.1080/14786419.2020.1744136
2018	Rapid Detection Method to Quantify Linamarin Content in Cassava	10.4172/2155-9821.1000342
2017	Nanotechnological Strategies to Improve Water Solubility of Commercially Available Drugs	10.2174/2468187307666161227171349
2017	Mature leaf concentrate of Sri Lankan wild type Carica papaya Linn. modulates nonfunctional and functional immune responses of rats	10.1186/s12906-017-1742-z
2016	Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.	10.1021/acs.molpharmaceut.6b00078
2015	Bis(1,5-cyclooctadiene)rhodium Tetrafluoroborate–(R)-2,2′-Bis(diphenylphosphino)-1,1′-binaphthyl	10.1002/047084289X.RB119.PUB2
2014	Effect of pendant group on pDNA delivery by cationic-β-cyclodextrin:alkyl-PVA-PEG pendant polymer complexes.	10.1021/bm401096v
2012	Studies towards the synthesis of neuraminidase inhibitors and stereoselective synthesis of the C21-C34 subunit of aplyronines	N/A